HBIO earnings: next report 2026-08-10, real EPS beat/miss history, analyst consensus Buy, P/E -2.79. Updated 2026-07-23.
Harvard Bioscience (HBIO) Research Hub
Harvard Bioscience (HBIO) trades on NASDAQ, US in the Healthcare (Medical - Instruments & Supplies) sector. As of 2026-09-11, shares last closed at 8.03 USD (+1.01%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.79, market cap 0.03B. This hub links to the full technical, earnings and options research available for HBIO.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Instruments & Supplies) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 8.03 USD (+1.01%) |
| 52-week range | 5.77 USD – 8.37 USD |
| Trend regime | Range |
| 14-day RSI | 77.9 (Overbought) |
| Trailing P/E | -2.79 |
| Market cap | 0.03B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-10 |
Available research for HBIO
Covered Call on HBIO: how it works, illustrative setup around the real 8.03 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HBIO: how it works, illustrative setup around the real 8.03 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HBIO: how it works, illustrative setup around the real 8.03 USD price, max profit/loss, breakeven and when to use it. Educational.
HBIO technical analysis: range, last 8.03 USD, RSI 77.9, 52w range 5.77 USD–8.37 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is HBIO in?
Harvard Bioscience (HBIO) is classified under Healthcare (Medical - Instruments & Supplies), listed on NASDAQ, US.
Is HBIO in an uptrend or downtrend?
As of 2026-09-11, HBIO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is HBIO's trailing P/E ratio?
HBIO's trailing P/E is -2.79, with a market cap of 0.03B. See the earnings research page for full valuation detail.
When does HBIO next report earnings?
HBIO is next scheduled to report earnings on 2026-08-10, with a consensus EPS estimate of -0.21 USD.